Prevention of cholesterol gallstone disease by schaftoside in lithogenic diet-induced C57BL/6 mouse model
- 1 November 2017
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 815, 1-9
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81303297)
- Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine
This publication has 56 references indexed in Scilit:
- Tributyltin chloride induces ABCA1 expression and apolipoprotein A-I-mediated cellular cholesterol efflux by activating LXRalpha/RXRBiochemical Pharmacology, 2011
- Overexpression of Sterol Carrier Protein 2 in Patients with Hereditary Cholesterol GallstonesBMC Gastroenterology, 2011
- Functional and genetic analysis in type 2 diabetes of Liver X receptor alleles – a cohort studyBMC Medical Genetics, 2009
- Roles of Infection, Inflammation, and the Immune System in Cholesterol Gallstone FormationGastroenterology, 2009
- Apical sodium bile acid transporter and ileal lipid binding protein in gallstone carriersJournal of Lipid Research, 2006
- Progressive familial intrahepatic cholestasis: Genetic disorders of biliary transportersJournal of Gastroenterology and Hepatology, 2005
- Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanismsJournal of Hepatology, 2004
- Regulation of ATP-binding Cassette Sterol Transporters ABCG5 and ABCG8 by the Liver X Receptors α and βJournal of Biological Chemistry, 2002
- Gallstone Formation and Weight LossObesity Research, 1993
- The physical chemistry of cholesterol solubility in bile. Relationship to gallstone formation and dissolution in man.Journal of Clinical Investigation, 1978